Literature DB >> 19861679

Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia.

Cynthia L Fisher1, Nicolas Pineault, Christy Brookes, Cheryl D Helgason, Hideaki Ohta, Caroline Bodner, Jay L Hess, R Keith Humphries, Hugh W Brock.   

Abstract

The Additional sex combs like 1 (Asxl1) gene is 1 of 3 mammalian homologs of the Additional sex combs (Asx) gene of Drosophila. Asx is unusual because it is required to maintain both activation and silencing of Hox genes in flies and mice. Asxl proteins are characterized by an amino terminal homology domain, by interaction domains for nuclear receptors, and by a C-terminal plant homeodomain protein-protein interaction domain. A recent study of patients with myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) revealed a high incidence of truncation mutations that would delete the PHD domain of ASXL1. Here, we show that Asxl1 is expressed in all hematopoietic cell fractions analyzed. Asxl1 knockout mice exhibit defects in frequency of differentiation of lymphoid and myeloid progenitors, but not in multipotent progenitors. We do not detect effects on hematopoietic stem cells, or in peripheral blood. Notably, we do not detect severe myelodysplastic phenotypes or leukemia in this loss-of-function model. We conclude that Asxl1 is needed for normal hematopoiesis. The mild phenotypes observed may be because other Asxl genes have redundant function with Asxl1, or alternatively, MDS or oncogenic phenotypes may result from gain-of-function Asxl mutations caused by genomic amplification, gene fusion, or truncation of Asxl1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19861679      PMCID: PMC2803690          DOI: 10.1182/blood-2009-07-230698

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

Review 1.  The Polycomb group--no longer an exclusive club?

Authors:  H W Brock; M van Lohuizen
Journal:  Curr Opin Genet Dev       Date:  2001-04       Impact factor: 5.578

2.  Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny.

Authors:  Nicolas Pineault; Cheryl D Helgason; H Jeffrey Lawrence; R Keith Humphries
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

Review 3.  Retinoids and their receptors in cancer development and chemoprevention.

Authors:  Shi-Yong Sun; Reuben Lotan
Journal:  Crit Rev Oncol Hematol       Date:  2002-01       Impact factor: 6.312

4.  Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.

Authors:  J J Jacobs; P Keblusek; E Robanus-Maandag; P Kristel; M Lingbeek; P M Nederlof; T van Welsem; M J van de Vijver; E Y Koh; G Q Daley; M van Lohuizen
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

5.  Additional sex combs-like 1 belongs to the enhancer of trithorax and polycomb group and genetically interacts with Cbx2 in mice.

Authors:  C L Fisher; I Lee; S Bloyer; S Bozza; J Chevalier; A Dahl; C Bodner; C D Helgason; J L Hess; R K Humphries; H W Brock
Journal:  Dev Biol       Date:  2009-10-13       Impact factor: 3.582

6.  Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stage.

Authors:  S Tokimasa; H Ohta; A Sawada; Y Matsuda; J Y Kim; S Nishiguchi; J Hara; Y Takihara
Journal:  Exp Hematol       Date:  2001-01       Impact factor: 3.084

7.  Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement.

Authors:  I-Hsin Su; Ashwin Basavaraj; Andrew N Krutchinsky; Oliver Hobert; Axel Ullrich; Brian T Chait; Alexander Tarakhovsky
Journal:  Nat Immunol       Date:  2002-12-23       Impact factor: 25.606

8.  Characterization of mouse clonogenic megakaryocyte progenitors.

Authors:  Thanyaphong Na Nakorn; Toshihiro Miyamoto; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-18       Impact factor: 11.205

9.  Disruption of E2F signaling suppresses the INK4a-induced proliferative defect in M33-deficient mice.

Authors:  Nathalie Coré; Florence Joly; Annie Boned; Malek Djabali
Journal:  Oncogene       Date:  2004-10-07       Impact factor: 9.867

10.  Polycomb group gene rae28 is required for sustaining activity of hematopoietic stem cells.

Authors:  Hideaki Ohta; Akihisa Sawada; Ji Yoo Kim; Sadao Tokimasa; Seiji Nishiguchi; R Keith Humphries; Junichi Hara; Yoshihiro Takihara
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

View more
  71 in total

Review 1.  Epigenetics in myelodysplastic syndromes.

Authors:  Michael Heuser; Haiyang Yun; Felicitas Thol
Journal:  Semin Cancer Biol       Date:  2017-08-02       Impact factor: 15.707

Review 2.  Disordered epigenetic regulation in the pathophysiology of myeloproliferative neoplasms.

Authors:  Su-Jiang Zhang; Omar Abdel-Wahab
Journal:  Curr Hematol Malig Rep       Date:  2012-03       Impact factor: 3.952

Review 3.  Molecular biology of myelodysplastic syndromes.

Authors:  Alan H Shih; Ross L Levine
Journal:  Semin Oncol       Date:  2011-10       Impact factor: 4.929

4.  Epigenetics and mutations in chronic myeloproliferative neoplasms.

Authors:  Alessandro M Vannucchi; Flavia Biamonte
Journal:  Haematologica       Date:  2011-10       Impact factor: 9.941

Review 5.  Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer.

Authors:  Martin Sauvageau; Guy Sauvageau
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

Review 6.  JAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg?

Authors:  Linda M Scott; Vivienne I Rebel
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 7.  Epigenetic alterations in hematopoietic malignancies.

Authors:  Young Rock Chung; Emma Schatoff; Omar Abdel-Wahab
Journal:  Int J Hematol       Date:  2012-09-27       Impact factor: 2.490

Review 8.  Molecular aspects of myeloproliferative neoplasms.

Authors:  François Delhommeau; Dorota Jeziorowska; Christophe Marzac; Nicole Casadevall
Journal:  Int J Hematol       Date:  2010-02-27       Impact factor: 2.490

Review 9.  The Role of Additional Sex Combs-Like Proteins in Cancer.

Authors:  Jean-Baptiste Micol; Omar Abdel-Wahab
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

Review 10.  Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?

Authors:  Stephanie Beurlet; Christine Chomienne; Rose Ann Padua
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.